Does the Mixed Opioid Receptor Antagonist Naltrexone Mitigate Stimulant-Induced Euphoria?: A Double-Blind, Placebo Controlled Trial of Naltrexone

View/Open

TSDOD_Liking_MS_Current.docx (83.67Kb)

Access Status

Full text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.

Author

Spencer, Thomas J.

Bhide, Pradeep

Zhu, Jinmin

Faraone, Stephen V.

Fitzgerald, Maura

Yule, Amy

Uchida, Mai

Spencer, Andrea Morris

Hall, Anna M.

Koster, Ariana J.

Feinberg, Leah

Kassabian, Sarah

Storch, Barbara

Biederman, Joseph

Metadata

Show full item record

Citation

Thomas J. Spencer, MD; Pradeep Bhide, PhD; Jinmin Zhu, PhD; Stephen V. Faraone, PhD; Maura Fitzgerald, MPH; Amy M. Yule, MD; Mai Uchida, MD; Andrea E. Spencer, MD; Anna M. Hall, BA; Ariana J. Koster, BS; Leah Feinberg, BS; Sarah Kassabian, BS ; Barbara Storch, BS; Joseph Biederman, MD. Does the Mixed Opioid Receptor Antagonist Naltrexone Mitigate Stimulant-Induced Euphoria?: A Double-Blind, Placebo Controlled Trial of Naltrexone. Journal of Clinical Psychiatry, 2017.

Citable link to this page

https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37373103